Evidence map›Paper›PMID 31875985›Full record

ArticleJournal of cellular physiology2020

Absence of VEGFR-1/Flt-1 signaling pathway in mice results in insensitivity to discogenic low back pain in an established disc injury mouse model.

Sujun Qiu, Changgui Shi, Arivarasu Natarajan Anbazhagan, Vaskar Das, Vipin Arora, Ranjan Kc, Xin Li, InSug O-Sullivan, Andre van Wijnen, Sudhakar Chintharlapalli and 6 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Updates on Pathophysiology of Discogenic Back Pain.Journal of clinical medicine · 2023
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Epigallocatechin-3-Gallate Protects HDrug design, development and therapy · 2020
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 4 countries.

Sujun QiuDepartment of Spinal Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.ORCID 0000-0001-9109-9277
Changgui ShiDepartment of Orthopedic Surgery, Changzheng Hospital, The Second Military Medical University of China, Shanghai, China.
Arivarasu Natarajan AnbazhaganDepartment of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Vaskar DasDepartment of Anesthesiology, Rush University Medical Center, Chicago, Illinois.
Vipin AroraDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Ranjan KcDivision of Orthopedic Surgery, The Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania.
Xin LiDepartment of Bioengineering, University of Illinois at Chicago, Chicago, Illinois.
InSug O-SullivanDepartment of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Andre van WijnenDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-4458-0946
Sudhakar ChintharlapalliDepartment of Immuno-oncology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana.
Gina Gott-VelisDepartment of Bioengineering, University of Illinois at Chicago, Chicago, Illinois.
Ripper RichardDepartments of Anesthesiology, University of Illinois at Chicago, Chicago, Illinois.
Fackson MwaleOrthopaedics Research Laboratory, Lady Davis Institute for Medical Research, SMBD-Jewish General Hospital, Montreal, Quebec, Canada.
Masabumi ShibuyaDivision of Genetics, Institute of Physiology and Medicine, Jobu University, Takasaki, Japan.
Shaoxiong MinDepartment of Spinal Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Hee-Jeong ImDepartment of Bioengineering, University of Illinois at Chicago, Chicago, Illinois.
University of Illinois Chicago · USZhujiang Hospital · CNChildren's Hospital of Philadelphia · USEli Lilly (United States) · USJewish General Hospital · CAJobu University · JPMassachusetts General Hospital · USMayo Clinic · USRush University Medical Center · USSecond Military Medical University · CN

Funding

Validation of Novel Target for OA TreatmentR01AR077890 · NIAMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ROYSTON, THOMAS J · 2020 to 2020
$4.2M
Allosteric Small Molecule Inhibitor Of Nerve Growth Factor Signaling in Low Back PainR21AR067935 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI CHEN, DI · 2015 to 2016
$375k
OSTEOARTHRITIS AND KNEE JOINT PAINI01BX002647 · VA · JESSE BROWN VA MEDICAL CENTER · PI SAMPEN, HEE-JEONG IM · 2015 to 2023
–
BLRD VA I01 BX002647NIAMS NIH HHS R01 AR077890NIAMS NIH HHS R21 AR067935
6 · The paper itself

Abstract

Although degenerative disc disease (DDD) and related low back pain (LBP) are growing public health problems, the underlying disease mechanisms remain unclear. An increase in the vascular endothelial growth factor (VEGF) levels in DDD has been reported. This study aimed to examine the role of VEGF receptors (VEGFRs) in DDD, using a mouse model of DDD. Progressive DDD was induced by anterior stabbing of lumbar intervertebral discs in wild type (WT) and VEGFR-1 tyrosine-kinase deficient mice (vegfr-1

Indexed as

AnimalsDisease Models, AnimalGanglia, SpinalGene Expression RegulationHumansIntervertebral DiscLow Back PainLumbar VertebraeMicePain MeasurementSignal TransductionVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseVascular Endothelial Growth Factor Receptor-1discogenic low back painintervertebral disc degenerationmouse disc degeneration disease modelvascular endothelial growth factorvascular endothelial growth factor receptor-1

Identifiers

PMID31875985
PMCPMC9782756
OpenAlexW2998182049

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.